Spots Global Cancer Trial Database for Patient Satisfaction and Quality of Life Impact - PecFent®
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Patient Satisfaction and Quality of Life Impact - PecFent®
Official Title: A French, Multicentre, Open-label, Observational Study to Assess Quality of Life and Satisfaction in Subjects Taking PecFent® for the Treatment of Breakthrough Cancer Pain (BTPc)
Study ID: NCT01693328
Conditions
Interventions
Study Description
Brief Summary: National multicenter, prospective, observational study in cancer patients with chronic background pain and breakthrough pain to whom PecFent® has been prescribed under pragmatic condition by a specialist in the treatment of cancer pain conditions. • Study objectives include assessment of early treatment satisfaction.
Detailed Description:
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Centre Léon-Bérard, Lyon, , France
Contact Details
Name: Alain Serrie, MD
Affiliation: Head of Pain Federation - Palliative Medicine Lariboisiere Hospital, Paris France
Role: PRINCIPAL_INVESTIGATOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
